{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-011455","form_type":"8-K","ticker":"TCMD","cik":"0001027838","company_name":"TACTILE SYSTEMS TECHNOLOGY INC","filed_at":"2022-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.641651+00:00","generated_at":"2026-06-24T06:16:38.302429+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tactile Medical Q2 revenue $59.6M (+17% YoY); raises FY22 revenue guidance to $238-242M","bullets":["Net loss $4.6M ($0.23/share) vs net income $1.3M ($0.07) in Q2 2021; adjusted EBITDA $1.7M vs $4.1M.","Airway clearance products added $8.0M revenue; lymphedema sales up 1% YoY.","Full-year 2022 revenue guidance raised to $238-242M from prior $235-240M (14-16% growth).","Operating loss widened to $4.1M from $0.1M; cash $23.4M, debt $50.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-011455","json":"https://secwatch.observer/filing/0001558370-22-011455.json","markdown":"https://secwatch.observer/filing/0001558370-22-011455.md","text":"https://secwatch.observer/filing/0001558370-22-011455.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1027838/000155837022011455/0001558370-22-011455-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1027838/000155837022011455/tcmd-20220801x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:16:38.302429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}